Professor Michaela Rumlová, head of a research group of the National Institute of Virology and Bacteriology at UCT Prague (and Vice-Rector for doctoral studies), holder of a licensed patent &nbsp;for antiretroviral testing assays, and recipient of the Czech Science Foundation’s President’s Award for HIV research, has also become the principal investigator of the bilateral INTER-EXCELLENCE II project “Cellular factors regulating the export and packaging of unspliced ​​retroviral RNA”, starting this year. In this interview, she explains how retroviruses such as HIV “hack” the cell in order to export their own genome from the nucleus into the cytoplasm, and then to the site where it is specifically packaged into nascent viral particles, a key step in viral replication. Her team is collaborating with the NIH (National Institutes of Health) and Rockefeller University to elucidate mechanisms that may help reveal new vulnerable points in the retrovirus replication cycle while simultaneously clarifying related cellular processes.<h5>Could you describe your project and its main objectives?</h5>Retroviruses, such as HIV, are viruses that carry genetic information in the form of RNA; however, after entering a cell, they are able to reverse transcribe it into DNA and integrate it into the host genome. In order to replicate, they must transport their genetic information—in the form of unspliced RNA—from the nucleus into the cytosol. There, it serves both as a template for the production of viral proteins and as the genome of new viral particles. This is highly unusual, as the cell very carefully controls which RNA molecules are allowed to leave the nucleus. Normal protein-coding cellular RNAs, known as messenger RNAs (mRNAs), must undergo splicing—a processing step in which certain segments are removed—before being exported. When this process fails, mRNA that retains these segments is held back in the nucleus as part of quality control and subsequently degraded. Retroviruses have managed to outwit this cellular control machinery, allowing their unspliced RNA to pass into the cytoplasm.Our project focuses on identifying the cellular proteins that assist retroviruses in this step and on the mechanism by which protein complexes bound to viral RNA are remodelled during RNA transport. The goal is to understand how the virus uses cellular mechanisms to its advantage and how this pathway is linked to the subsequent fate of the RNA, i.e. to its translation and packaging into new viral particles.<h5>Why is this export of unspliced ​​RNA so important for retroviral replication?</h5>Because this RNA has a dual role for the virus. On the one hand, it serves as a template for synthesizing viral proteins in the cytoplasm; on the other, it represents the genetic material itself, which must be packaged into new viral particles. The virus must package its RNA genome in its unspliced form, as only this RNA contains essential sequences without which further viral replication would be impossible.Simply put: the virus needs to get a complete copy of its genetic instructions out of the nucleus. Once the viral RNA is in the cytoplasm, it can be used as a template for synthesizing viral proteins; and a portion of these RNA molecules is then selected and packaged into a new particle as a genome. We are interested in how the virus forces the cell to allow viral RNA that is, from the cell’s perspective, “unfinished,” that is unspliced, to leave the nucleus. We are also investigating how the cell and the virus together - albeit unintentionally from the cell’s perspective - determine which RNA molecule will be translated into proteins and which will be packaged as the genome. This is one of the key, yet still not fully understood, steps of retroviral replication.<h5>What do you think it was about your project that impressed the Ministry of Education, Youth and Sports’ jury the most?</h5>I believe the decisive factor was a combination of several elements. First, the reviewers were primarily interested in the scientific problem itself. We are investigating a mechanism that is essential for retroviruses, but still not sufficiently understood, which may also have broader implications for the regulation of cellular processes. In addition, the quality of the team, our strong collaboration with the NIH and Rockefeller University, and the use of modern methods that will allow us to track viral RNA in great detail also played a role. It was also important that the project has clear objectives and a realistic plan.<h5>How will this research contribute to the development of new treatments for retroviral infections?</h5>It is important to say that this is primarily basic research. Rather than developing a new drug directly, we are trying to understand, at the molecular level, the step that the virus cannot do without. Only when we fully understand the mechanism of these cellular processes and identify the essential factors for the export of unspliced ​​RNA and how they function, will we be able to better determine which interactions or mechanisms represent potentially vulnerable points. Similar mechanisms associated with the export of unspliced ​​mRNA also appear in some diseases, such as cancer, so I &nbsp;see the benefit of our research mainly in that it will refine our understanding of these pathological processes in the cell, and retroviruses help us do so. Therefore, our work on retroviruses not only shows us how the virus works, but also how the cell itself works.<h5>What responsibilities does your UCT Prague team have? How does the collaboration with your American partners work?</h5>At UCT Prague, we are conducting the project’s primary experimental work. Our research involves cell cultures, viral models, and various biochemical techniques ranging from immunochemistry to microscopy that allow us to track viral RNA and identify its cellular partners. In collaboration with colleagues from NIH, Frederick, we are developing single-particle tracking methods to observe viral RNA movement in living cells across both space and time. Furthermore, we are working with colleagues from Rockefeller University to employ iCLIP methods for the precise mapping of protein-binding sites on RNA. Both collaborations are valuable to us, because they are not just about data sharing, but also about the transfer of expertise and detailed know-how.<h5>Who else is collaborating on the project?</h5>At UCT Prague, we collaborate closely with the Department of Biotechnology and the Department of Biochemistry and Microbiology. Externally, we work with colleagues from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague) and the Central European Institute of Technology in Brno (CEITEC). Our research naturally necessitates the integration of diverse fields of expertise; it requires combining virology, cell biology, and biochemistry with advanced imaging and modern approaches to study RNA-protein interactions. This is exactly what makes our project capable of addressing complex questions that a single laboratory cannot tackle on its own.<h5>Are there plans to continue the project? Have you brought on new collaborators, and are you looking to welcome new colleagues to the team?</h5>Yes, definitely. In basic research, it often happens that one answered question opens up several more. High-quality, properly interpreted data provide a foundation you can build on — and that is what moves scientists forward. It is already clear that the topic of retroviral RNA export and packaging has broader implications and may reveal more general principles of how RNA functions within the cell. We also hope the project will be attractive to students, as it connects classical molecular biology, biochemistry, and virology with cutting-edge biotechnological methods. Students are already involved in the project as part of their bachelor’s and master’s theses.<h5>What was the personal turning point that motivated you to pursue a long-term investigation into retroviral particles?</h5>I first encountered retroviruses in the early 1990s during my diploma thesis, when I was working at IOCB Prague on HIV-1 protease inhibitors. At that time, AIDS could not yet be effectively treated, and retrovirus research had a completely different dimension. From the very beginning, I was fascinated by how such a relatively small and simple virus can outsmart evolutionarily highly optimized cellular processes and turn them to its own advantage. And that has never stopped fascinating me. From a scientific point of view, retroviruses are remarkable; just consider one of their enzymes, reverse transcriptase, without which no diagnostic or research laboratory in the world could function today. Without it, it would be impossible to diagnose RNA viruses like SARS-CoV-2, influenza, or HIV using RT-PCR tests, or, for example to produce recombinant human proteins in bacterial cells.

Tracking unspliced RNA: Professor Rumlová studies how retroviruses “hack” cells

News from LabRulezLCMS Library - Week 20, 2026

🎤Lindsay Repka&nbsp;Lindsay Repka is a chemistry professor at Middlebury College whose research explores photoredox chemistry, catalyst stability, and visible-light-driven transformations. Her lab emphasizes both mechanistic insight and hands-on student training in advanced analytical instrumentation.In this episode of Concentrating on Chromatography, we sit down with Lindsay Repka to discuss how LC-MS and GC-MS transformed her lab’s approach to photoredox chemistry.What began as a project to develop a visible-light photocrosslinking handle unexpectedly led to a major discovery: the solvent (DMF) was reacting with the photocatalyst itself. Using high-resolution LC-MS, Lindsay’s team observed multiple solvent adducts forming — sometimes with complete catalyst consumption. That discovery reshaped their research direction.This episode is a rare deep dive into both LC-MS and GC-MS within the same research project, showing how chromatography-driven insight can turn unexpected degradation into productive new reactivity.If you work in:<ul><li>Photoredox chemistry</li><li>Reaction optimization</li><li>Mass spectrometry method development</li><li>Catalyst screening</li><li>Academic synthetic chemistry</li></ul>…this conversation will resonate.<h4>Key Topics Covered</h4><ul><li>Photocatalyst stability in DMF, DCE, and MeCN</li><li>Demethylation under mild visible-light conditions</li><li>High-resolution Q-TOF LC-MS quantitation</li><li>Internal standard methodology in GC-MS</li><li>Signal-to-noise improvement using extracted ion chromatograms</li><li>Reaction reproducibility and quality control strategy</li></ul><h3>Video Transcription</h3>In this interview, Lindsay Repka discusses the role of photoredox chemistry in method development, photocrosslinking, solvent activation, catalyst stability, and the use of LC-MS and GC-MS to understand reaction pathways.<h4>What is photoredox chemistry?</h4>Photoredox chemistry uses light to activate a photocatalyst, which can either donate or accept an electron from a substrate. This generates radical species that can undergo new types of reactivity.Repka explains that one of the key advantages of photoredox chemistry is its ability to operate under mild conditions, often using visible light. This makes it attractive for sensitive molecules and biological systems, including potential applications in drug release, live-cell chemistry, and drug development.<h4>Photocrosslinking and drug-target interactions</h4>Repka’s group initially aimed to develop visible-light photocrosslinking methods to study drug interactions with biological targets. Photocrosslinking can covalently link a drug to its target, making it easier to identify the biological target of a compound.Traditional photocrosslinking often uses UV light, but visible light offers milder and more biologically compatible conditions.<h4>From photocrosslinking to solvent activation</h4>The project shifted direction when the desired photocrosslinking reactions gave very low yields. Instead of reacting with amino acids as intended, the radical intermediate mainly reacted with itself.The team explored different solvents to stabilize the radical, but found that some solvents, such as DMF, were not inert. Instead, the solvent reacted with the photocatalyst or radical species, revealing unexpected solvent activation chemistry.<h4>Why LC-MS was critical</h4>LC-MS became essential because the reaction mixtures were too complex and low-yielding for NMR or GC-MS. High-resolution LC-MS allowed the team to detect minor products, identify photocatalyst modifications, and observe solvent addition products with high confidence.Repka emphasizes that LC-MS was both a qualitative and quantitative tool. It was used quantitatively to measure how much photocatalyst remained after light exposure, and qualitatively to identify degradation products and new reactivity pathways.<h4>Photocatalyst stability workflow</h4>The team developed a systematic workflow to evaluate photocatalyst stability under light exposure. Because catalyst degradation was time-sensitive, reproducibility required strict control of experimental conditions.Key steps included using a glove box, commercial deoxygenated solvents, accurate weighing on a microbalance, controlled light exposure in a photoreactor, and temperature control with a chiller. These precautions helped reduce day-to-day variability and enabled reproducible measurements of catalyst remaining.<h4>Quantifying catalyst remaining by LC-MS</h4>Calibration curves were prepared using pure photocatalyst solutions and LC-MS ion areas. The team worked in the nanomolar range to maintain linearity.Instead of relying only on total ion chromatograms, they used extracted ion chromatograms (EICs) to improve signal-to-noise for the photocatalyst signal. Baseline subtraction was also applied to reduce noise and improve quantitation at low concentrations.Calibration curves and quality control samples were prepared and measured on the same day as the reaction samples, because LC-MS signal intensity can vary significantly from day to day.<h4>Why GC-MS was used later</h4>For demethylation studies, the group moved to GC-MS because the substrates and products were small and volatile enough for gas chromatography. GC-MS was better suited for rapidly screening many reaction conditions, including different photocatalysts, solvents, and oxidants.Instead of generating full calibration curves for every experiment, the team used an internal standard to streamline analysis and determine percent conversion based on relative response factors.<h4>Practical lessons from the project</h4>Repka highlights the importance of careful sample preparation, especially when working with very small quantities of photocatalysts. A high-quality microbalance, stable granite platform, antistatic tools, and aluminum weigh boats improved weighing accuracy and reproducibility.She also argues that mass spectrometry should be a standard part of photoredox method development because it can reveal minor products, support reaction optimization, and provide insights that may be difficult or impossible to obtain by NMR alone.<h4>Final perspective</h4>Beyond the chemistry, Repka emphasizes the importance of student training and mentoring. For her, research is not only about discovering new reactivity but also about giving students practical experience, helping them develop independence, and preparing them for future scientific careers.<blockquote>This text has been automatically transcribed from a video presentation using AI technology. It may contain inaccuracies and is not guaranteed to be 100% correct.</blockquote><blockquote><h4>Concentrating on Chromatography Podcast</h4>Dive into the frontiers of chromatography, mass spectrometry, and sample preparation with host David Oliva. Each episode features candid conversations with leading researchers, industry innovators, and passionate scientists who are shaping the future of analytical chemistry. From decoding PFAS detection challenges to exploring the latest in AI-assisted liquid chromatography, this show uncovers practical workflows, sustainability breakthroughs, and the real-world impact of separation science. Whether you’re a chromatographer, lab professional, or researcher you'll discover inspiring content!You can find Concentrating on Chromatography Podcast in podcast apps:<ul><li><a target="_blank" rel="noopener noreferrer" href="https://open.spotify.com/show/1wZg67rCjoGju4yhqxI3tL">Spotify</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podcasts.apple.com/tz/podcast/concentrating-on-chromatography/id1788429185">Apple podcast</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podscan.fm/podcasts/concentrating-on-chromatography">podscan</a></li></ul>and on <a target="_blank" rel="noopener noreferrer" href="https://www.youtube.com/@ChromatographyTalk/videos">YouTube channel</a></blockquote>

Using LC-MS & GC-MS to Decode Photoredox Catalyst Stability

Article

Application

Video

Scientists

Interview

Science and research

The University of Chemistry and Technology, Prague is a natural centre of first-rate study and research in the area of chemistry in Czechia and is one of the country's largest educational and research institutions focused on technical chemistry, chemical and biochemical technologies, material and chemical engineering, food chemistry, and environmental studies.

UCT Prague

Everything from the world of analytical chemistry in one place. We connect people in solving their problems. At Labrulez you will find all the necessary information easily, quickly and clearly. Stop searching and start finding.

LabRulez

Organomation, founded in 1959, designs and manufactures high-quality nitrogen evaporators and extraction systems. Known for innovation and durability, their lab instruments are used globally for efficient sample preparation with strong customer support.

Organomation

Agilent Technologies

Technology Networks

ACD/Labs

Thermo Fisher Scientific

OpenLab CDS contains a very powerful reporting engine built on the industry standard of Microsoft’s Business Intelligence Studio. It affords an opportunity to create customized reports that minimize or eliminates a laboratory’s dependence on excel. This session will introduce users to the types of reports Agilent includes with the software, along with how to customize those reports to include your own calculations.
<blockquote>
Presenter: Richard Mutkoski (Laboratory Informatics Application Engineer, Agilent Technologies, Inc.)
</blockquote>
<blockquote>
Richard Mutkoski began with Agilent (HP) in 1995. He has been an Application Engineer in Agilent’s Laboratory Informatics for the past 16 years. Prior to his career at Agilent Rich spent 12 years in a variety of small pharmaceutical firms in both R&amp;D and QA/QC capacities affording him first-hand knowledge of those workflows, bottlenecks and challenges.
</blockquote>

Agilent Technologies: Introduction to OpenLab CDS Custom Reporting

Introduction to OpenLab CDS Custom Reporting

This demonstration will concentrate on the enhanced workflows and capabilities of OpenLab CDS.
<h3>During this 1-hour session you will:</h3>
<ul>
<li>Learn about the function and advantages of the new control panel including creating instruments, creating projects, activity logs, storage types and paths.</li>
<li>Explore the basic operations of user privileges including assigning permissions and roles, and license utilities.</li>
<li>Learn the basics of how to setup instruments, methods and sequences.</li>
<li>Explore the enhanced data processing workflow including auto and manual integration, e-signatures and audit trail review</li>
<li>Discover uses for the Custom Calculator and its functionality</li>
<li>Learn how to customize reports with the Intelligent Reporter to generate calculations without to use of Excel</li>
</ul>
<blockquote>
Presenter: Richard Mutkoski (Application Engineer, Agilent Technologies, Inc.)
</blockquote>
<blockquote>
Richard Mutkoski began with Agilent (HP) in 1995. He has been an Application Engineer in Agilent’s Laboratory Informatics for the past 16 years. Prior to his career at Agilent Rich spent 12 years in a variety of small pharmaceutical firms in both R&amp;D and QA/QC capacities affording him first-hand knowledge of those workflows, bottlenecks and challenges.
</blockquote>

Agilent Technologies: OpenLab CDS Introductory Demonstration

OpenLab CDS Introductory Demonstration

Even if you have robust quality systems governing your analytical laboratory and a strong data integrity program in place, you may still be nervous about preparing for a regulatory inspection. What will the inspectors want to know? What will they ask? Is your team prepared?
You can ease those fears by attending this two-part webcast. First, we will explain what you should expect during an inspection. Then, we will simulate an inspection to show you, in a realistic scenario, what an inspector might ask, and how you and your team should handle the questions, including when they don’t know all the answers or don’t understand all the questions. We will explain the scope of a data integrity inspection in a regulated laboratory, and our simulation of an inspection of a chromatography data system (CDS) will explain the roles of different people in a multi-person team that includes a laboratory manager and the CDS laboratory administrator.
<h3>What we will cover:</h3>
<ul>
<li>Background on data integrity and a chromatography data system (CDS)</li>
<li>Management involvement in data integrity</li>
<li>Qualification of chromatographs</li>
<li>Validation of analytical procedures</li>
</ul>
<h3>Key Learning Objectives:</h3>
<ul>
<li>Understand how data integrity plays a role in your inspection</li>
<li>Understand and answer the questions being asked</li>
<li>Understand the impact of poor analytical decisions</li>
<li>Use systems that can help demonstrate data integrity and regulatory compliance</li>
<li>Use technical controls to enforce operating procedures</li>
</ul>
<h3>Who Should Attend:</h3>
<ul>
<li>Analysts working in a regulated analytical laboratory</li>
<li>Chromatography data system (CDS) administrators</li>
<li>Laboratory managers</li>
<li>Quality assurance (QA) and quality control (QC) staff</li>
</ul>
<blockquote>
Presenter: Bob McDowall (Director, RD McDowall Limited, Bromley, Kent, UK)
</blockquote>
<blockquote>
Bob McDowall, PhD, is an analytical chemist with over 45 years of experience including 15 years working in the pharmaceutical industry and over 25 years working for the industry as a consultant. He is the director of R D McDowall Ltd, a consulting company offering services on process improvement, implementation of laboratory informatics applications, training staff in regulatory compliance, and qualification of IT infrastructure. Bob is a trained auditor and has been involved with the validation of computerized systems for over 30 years. He edited the first book on LIMS in 1987 and is the author of books on the validation of chromatography data systems and data integrity and data governance in regulated laboratories due to be published in late 2018. He was presented with the 1997 LIMS Award. He is a core industry expert for the GAMP Data Integrity Special Interest Group and was a subject matter expert contributor and reviewer of the 2017 GAMP Guide for Records and Data Integrity. He co-drafted the update to USP &lt;1058&gt; on Analytical Instrument Qualification (AIQ) for public comment that became effective in August 2017.
</blockquote>
<blockquote>
Presenter: Paul Smith (Global Compliance Specialist, Agilent Technologies, Cheadle, UK)
</blockquote>
<blockquote>
Paul is global compliance specialist with Agilent technologies. He has worked for Agilent for 9 years and has 35 years’ experience in the pharmaceutical and analytical area.
</blockquote>
<blockquote>
Presenter: Josh Miller (OpenLab Software Marketing – eLearning Expert, Agilent Technologies, Santa Clara, CA)
</blockquote>
<blockquote>
Josh is a professional chemist with 15 years’ experience in validating, supporting, deploying, and developing the OpenLab software suite of products. He is a true expert with all things OpenLab and has extensive experience with chromatography data system, electronic content management, business process management, instrument control products, and more. He has developed many of the training courses for OpenLab products and has served as an instructor for dozens of formal courses around the globe. In 2009, he created “eFamiliarization” to help customers learn the basics of OpenLab products in an interactive simulation of Agilent software. More recently he has transformed Agilent’s embedded software help systems to better serve customers by putting consistent and searchable content at their fingertips. You may also find a significant collection of video content that he produces to help users learn to use OpenLab products.
</blockquote>

LCGC/Agilent Technologies: Five Essentials for Surviving Your Next Laboratory Inspection: A Quality Control Example, Part 1

Five Essentials for Surviving Your Next Laboratory Inspection: A Quality Control Example, Part 1

The Control Panel is the gatekeeper to the system.
<ul>
<li>Learn how to enable authentication to allow chemist names to be placed on reports. </li>
<li>See how to configure system in a compliant environment and restrict users’ access to instruments and data. </li>
<li>Understand the use of Roles and Privileges to refine what users can do. </li>
<li>Understand the need, creation and use of Projects. </li>
<li>Explore how to set-up an Acquisition Method for a Virtual 3D HPLC and a Virtual 7890 GC. </li>
<li>Explore the software features that have been designed to help minimize sequence creation time and eliminate costly typographical errors.</li>
</ul>

Agilent Technologies: OpenLab CDS Virtual Masterclass Series

OpenLab CDS Virtual Masterclass Series Session 1 - The Control Panel and Data Acquisition

Explore the new look and feel of the Data Analysis engine.
<ul>
<li>Become acquainted with Integration Parameters and how to create a calibration curve for quantitation. </li>
<li>Investigate new software tools such as Peak Explorer, UV and MS Spectral capabilities, library searching and matching, peak purity and more.</li>
<li>Learn how to combine information from multiple results sets to track trends across time and instrumentation.</li>
</ul>

OpenLab CDS Virtual Masterclass Series Session 2 - Data Analysis

Thermo Scientific™ Chromeleon™ CDS Software is full of features and tools to make your instrument operation, data collection, and analysis efficient and compliant. Remembering and using them all routinely is more of a challenge. We will show you how to use the software to its full potential.
<blockquote>
Presenter: Joshua Coiner (Product Specialist, Thermo Fisher Scientific)
</blockquote>
<blockquote>
Joshua is an enterprise CDS specialist. In his 10+ years with Thermo Fisher Scientific, he has filled Field Service, management, and now a sales role. Each role has afforded him opportunities to train customers on the use and troubleshooting of Thermo Scientific™ Chromeleon™ CDS. As a degreed chemist, he delights in helping customers work smarter and more efficiently. He is also a huge Star Wars nerd.
</blockquote>

Thermo Scientific: Lab Hacks Webinar Series

Chromatography Data System Software Tips and Tricks

<h3>Webinar Summary</h3>
Often there is a natural trade-off between IT demands, such as reducing the number of different systems in use (standardization) or leveraging modern technologies (like cloud), and the increased productivity and compliance demands for your laboratory.
This compromise is now over. Learn how Thermo Scientific™ Chromeleon™ 7.3 Chromatography Data System (CDS) is the first CDS to truly meet the needs of both the IT and infrastructure team and the laboratory.
Now you can standardize without compromise with global deployment, system stability and data security, and still realize significant laboratory productivity gains!
<h3>Attend this webinar to learn how Chromeleon™ 7.3 CDS:</h3>
<ul>
<li>Can deliver productivity gains of up to a third</li>
<li>Leverages modern IT technologies to ensures business continuity and streamlining in deployment and leveraging modern IT technologies</li>
<li>Offers new features that will be invaluable to your lab</li>
</ul>
<blockquote>
Presenter: Darren Barrington-Light, Senior Manager Product Marketing, Thermo Fisher Scientific™
</blockquote>

Technology Networks: The New No-compromise Enterprise CDS Solution

The New No-compromise Enterprise CDS Solution

Improvements in mass spectrometry have generated an increasing demand for analysis of more complicated samples by mass spectrometry (MS). While liquid chromatography (LC) and gas chromatography (GC) are effective at reducing sample complexity, co-elution of components is still not entirely avoidable. The reality of today&#39;s lab is:
<ul>
<li>A variety of instrument configurations and a multitude of software interfaces</li>
<li>Mountains of complex data for analysis</li>
</ul>
Struggle no more!
Join us to learn how vendor-neutral software can help you deformulate samples more efficiently leveraging knowledge from both the wider scientific community and your organization. See how third-party software enables you to:
<ul>
<li>Separate co-eluting components</li>
<li>Identify known and unknown components</li>
<li>Store, share, and leverage expertise</li>
</ul>
Hear about recent enhancements to these tools and see a sneak-peek of enhancements yet to come.
<h3>Intended Audience</h3>
<ul>
<li>Mass Spectrometrists</li>
<li>Analytical Chemists</li>
<li>Analytical Lab Managers/Directors</li>
</ul>
<blockquote>
Presenter: Anne Marie Smith, Senior Application Scientist at ACD/Lab
</blockquote>
<blockquote>
She received her Ph.D. in Chemical Biology from McMaster University where she developed MALDI-MS based assays for screening aminoglycoside kinases. After graduating she was employed as an Associate Scientist with Gilead Sciences in Alberta where her work focused primarily on impurity identification by LC/MS and LC method development. At ACD/Labs Anne Marie applies her hands-on experience with MS instruments and scientific software packages, plus knowledge of chromatographic method validation, to help customers implement our MS solutions and troubleshoot any technical challenges.
</blockquote>
<blockquote>
Host: Sanji Bhal is the Director of Marketing &amp; Communications at ACD/Labs.
</blockquote>
<blockquote>
Prior to joining ACD/Labs she was a lab-coat wearing medicinal chemist at Signalgene Inc., where she pursued her ongoing interest in cancer research, followed by a stint with the CRO NAEJA Pharmaceuticals. Sanji began her career in the U.K., completing her Ph.D. in synthetic organic chemistry at the University of Reading, and a post-doctoral fellowship at Cancer Research UK. Today Sanji is passionate about understanding the challenges still faced by scientists and R&amp;D organizations, and helping to &#39;match-make&#39; their needs with the tools available to support their innovations.
</blockquote>

Pixabay/Gerd Altmann:  Practical Steps for Efficient Deconvolution of LC/MS and GC/MS Data for Deformulation

LCMS webinars focusing on Software - page 57